At the close of business on 05 December 2022, Morten Opstad, Chair of the Board
of IDEX Biometrics ASA, held the following voting rights in IDEX, for the
purpose of the Extraordinary General Meeting on 09 December 2022:
Total 238,903,559 shares or 21,38% of the share capital and votes, consisting of
the following:
* Proxy to represent and vote for 70,224,923 shares or 6,29% of the share
capital, including shares held by Mr Opstad and close relations
* Proxy with voting instructions for 168,678,636 shares or 15,1% of the share
capital.
For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
(https://www.globenewswire.com/Tracker?data=oK5zwNtRsZ1s5umKWlj0gvhxK4PRPMGHg8q9
WpY79SVXH4zYq--0sgcQP_Odo0-K69jgeZX2OpVVepCuqIf4kSf6qGBkxSGU_Vjk3s4scM-PtiXZkVss
8JPP0gq8wLKP)
Tel: + 47 918 00186
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
touch-free authentication for all. We help people make payments, prove their
identity, gain access to information, unlock devices or gain admittance to
buildings. We invent, engineer, and commercialize these secure, yet incredibly
user-friendly solutions. Our total addressable market represents a fast growing
multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act